The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $23.24

Today's change-0.18 -0.77%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $23.24

Today's change-0.18 -0.77%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

Sabra Health Care REIT Inc down (U.S.)$0.18

Sabra Health Care REIT Inc closed lower Thursday, dropping (U.S.)$0.18 or 0.77% to (U.S.)$23.24. Over the last five days, shares have lost 6.97% and are down 23.48% for the last year to date. This security has underperformed the S&P 500 by 16.52% during the last year.

Key company metrics

  • Open(U.S.) $23.50
  • Previous close(U.S.) $23.42
  • High(U.S.) $23.65
  • Low(U.S.) $23.18
  • Bid / Ask(U.S.) $22.00 / (U.S.) $27.20
  • YTD % change-23.48%
  • Volume354,827
  • Average volume (10-day)365,057
  • Average volume (1-month)352,956
  • Average volume (3-month)492,251
  • 52-week range(U.S.) $23.18 to (U.S.) $34.44
  • Beta1.10
  • Trailing P/E19.67×
  • P/E 1 year forward18.79×
  • Forward PEG4.76×
  • Indicated annual dividend(U.S.) $1.64
  • Dividend yield7.06%
  • Trailing EPS(U.S.) $1.18
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+35.73%

Based on its net profit margin of 35.73%, Sabra Health Care REIT Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.38%Sector:Cyclical Consumer Goods & ServicesIndustry:Hotels, Motels & Cruise Lines
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue57565644
Total other revenue--------
Total revenue57565644
Gross profit--------
Total cost of revenue--------
Total operating expense41363827
Selling / general / administrative13896
Research & development--------
Depreciation / amortization14141410
Interest expense (income), net operating14141411
Unusual expense (income)0000
Other operating expenses, total--------
Operating income15201817
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets2--4--
Other--------
Income before tax17192217
Income after tax17192217
Income tax, total------0
Net income17192217
Total adjustments to net income-3-3-3-3
Net income before extra. items17192217
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items14172015
Inc. avail. to common incl. extra. items14172015
Diluted net income14172015
Dilution adjustment------0
Diluted weighted average shares60605648
Diluted EPS excluding extraordinary itemsvalue per share0.240.280.350.31
Dividends per sharevalue per share0.390.450.390.38
Diluted normalized EPSvalue per share0.210.280.280.31